Zota Health Care LImited
The current stock price of Zota Health Care LImited is ₹1,004.00, with a target price range between ₹953.80 and ₹1,054.20. The stock has experienced a price change of ₹-11.30 (-1.11%), reflecting recent market volatility.
Today's opening price was ₹1,022.00, while the previous close stood at ₹1,015.30. The intraday high reached ₹1,043.00, and the low touched ₹985.50. The volume-weighted average price (VWAP) is currently ₹1,012.34, indicating the stock's average traded price.
The market trend suggests a potential downtrend, with investors exercising caution due to recent declines. Analysts recommend closely monitoring support levels.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Zota Health Care LImited Price Chart
Zota Health Care LImited Pre Open Market Overview: 05-Feb-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 1022
- Previous Close Price: 1015.3
- Change: 6.70%
- Total Traded Volume: 763
- Total Buy Quantity: 6,144
- Total Sell Quantity: 5,535
Price | Buy Qty | Sell Qty |
---|---|---|
1,009.30 | 5.00 | 0.00 |
1,015.20 | 25.00 | 0.00 |
1,015.30 | 131.00 | 0.00 |
1,015.50 | 3.00 | 0.00 |
1,019.30 | 1.00 | 0.00 |
1,022.00 | 0.00 | 42.00 |
1,023.00 | 0.00 | 44.00 |
1,023.90 | 0.00 | 250.00 |
1,023.95 | 0.00 | 1.00 |
1,024.00 | 0.00 | 300.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
Bid | Qty | Ask | Qty |
---|---|---|---|
0.00 | 0 | 0.00 | 0 |
0.00 | 0 | 0.00 | 0 |
0.00 | 0 | 0.00 | 0 |
0.00 | 0 | 0.00 | 0 |
0.00 | 0 | 0.00 | 0 |
Shareholding Patterns (in %) of Zota Health Care LImited
Category | 06-Apr-2024 | 30-Jun-2024 | 14-Aug-2024 | 30-Sep-2024 | 31-Dec-2024 |
---|---|---|---|---|---|
Promoter & Promoter Group | 64.45 | 64.44 | 62.40 | 62.40 | 62.02 |
Public | 35.55 | 35.56 | 37.60 | 37.60 | 37.98 |
Shares held by Employee Trusts | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
Key Trade Statistics of Zota Health Care LImited
The trade information for Zota Health Care LImited includes a total traded volume of 0.98 lakh shares, and a traded value of ₹9.95 crore.
The market cap is ₹2,751.73 crore, with a free float market cap of ₹751.18 crore. The deliverable quantity is 43,805.00 shares, reflecting 44.55% of total trades.
Key risk indicators include security VaR at 18.54% and an applicable margin rate of 22.04%.
Trade Information | Details |
---|---|
Traded Volume (Lakhs) | 0.98 |
Traded Value (₹ Cr.) | 9.95 |
Total Market Cap (₹ Cr.) | 2,751.73 |
Free Float Market Cap (₹ Cr.) | 751.18 |
Impact cost | 0.17 |
Quantity Traded | 98,327.00 |
Deliverable Quantity | 43,805.00 |
% of Quantity to Traded | 44.55 |
Security VaR | 18.54 |
Index VaR | N/A |
VaR Margin | 18.54 |
Extreme Loss Rate | 3.5 |
Adhoc Margin | N/A |
Applicable Margin Rate | 22.04 |
Face Value | 10 |
Key Price Statistics of Zota Health Care LImited
The 52-week high for Zota Health Care LImited was ₹1,060.00, recorded on 16-Jan-2025. On the other hand, the 52-week low stands at ₹440.10, with the lowest value recorded on 04-Jun-2024.
The upper band for trading is ₹N/A, and the lower band is ₹N/A. The price band is 20%.
The stock's daily volatility stands at 2.83, while the annualized volatility is 54.07. The tick size for trading is ₹N/A.
Price Information | Details |
---|---|
52 Week High (16-Jan-2025) | 1,060.00 |
52 Week Low (04-Jun-2024) | 440.10 |
Upper Band | 1,218.35 |
Lower Band | 812.25 |
Price Band (%) | 20 |
Daily Volatility | 2.83 |
Annualised Volatility | 54.07 |
Tick Size | 0.05 |
Key Securities Statistics of Zota Health Care LImited
Securities Information | Details |
---|---|
Status | Listed |
Trading Status | Active |
Date of Listing | 19-Aug-2019 |
Adjusted P/E | 0 |
Symbol P/E | 0 |
Index | NA |
Macro-Economic Sector | Healthcare |
Sector | Healthcare |
Industry | Pharmaceuticals & Biotechnology |
Basic Industry | Pharmaceuticals |
Security Status of Zota Health Care LImited
Title | Details |
---|---|
Board Status | Main |
Trading Segment | Normal Market |
Session No. | - |
Class of Shares | Equity |
SDD Compliance | - |
Name of Compliance Officer | - |
Announcements of Zota Health Care LImited
Subject | Date |
---|---|
Shareholders meeting | 05-Feb-2025 |
Copy of Newspaper Publication | 01-Feb-2025 |
Corrigendum | 31-Jan-2025 |
Agreements,Contracts,Arrangements,MOU-XBRL | 31-Jan-2025 |
Memorandum of Understanding/Agreements | 30-Jan-2025 |
Press Release | 28-Jan-2025 |
Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 15-Jan-2025 |
Copy of Newspaper Publication | 14-Jan-2025 |
Corporate Actions of Zota Health Care LImited
Face Value | Purpose | Ex-Date |
---|---|---|
10 | Annual General Meeting/Dividend - Re 1 Per Share | 20-Sep-2024 |
10 | Annual General Meeting/Dividend - Re 1 Per Share | 22-Sep-2023 |
10 | Annual General Meeting/Dividend - Rs 1.50 Per Share | 19-Sep-2022 |
10 | Annual General Meeting/ Dividend Rs 1 Per Share | 22-Sep-2021 |
10 | Annual General Meeting/Dividend - Re 1 Per Share | 17-Sep-2020 |
10 | Annual General Meeting/Dividend - Re 1 Per Share | 12-Sep-2019 |
Board Meetings of Zota Health Care LImited
Financial Results of Zota Health Care LImited
Qtr Ended | Tot. Income | Net P/L | EPS | Notes |
---|---|---|---|---|
30 Sep 2024 | 5,998 | 235 | 0.89 | |
30 Jun 2024 | 5,267 | 158 | 0.6 | |
31 Mar 2024 | 4,804 | 22 | 0.09 | |
31 Dec 2023 | 4,321 | 116 | 0.45 | |
30 Sep 2023 | 4,178 | 179 | 0.7 |
Company Directory of Zota Health Care LImited
Web Address | Office | Address | City |
---|---|---|---|
www.zotahealthcare.com | Registered Office | Zota House, 2/896, Hira Modi Street, Sagrampura | SURAT |
www.zotahealthcare.com | Registered Office | Zota House, 2/896, Hira Modi Street, Sagrampura | SURAT |
www.zotahealthcare.com | Transfer Agent | Satellite Corporate services Private Limited Office No. 106 and 107 Dattani Plaza, East West Compound, Andheri Kurla Road, Sakinaka, | MUMBAI |
www.zotahealthcare.com | Transfer Agent | Satellite Corporate services Private Limited Office No. 106 and 107 Dattani Plaza, East West Compound, Andheri Kurla Road, Sakinaka, | MUMBAI |
Insider Trading of Zota Health Care LImited
Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
---|---|---|---|
7(2) | VINODCHANDRA DHIRAJLAL MEHTA | 1561220 | Sell |
7(2) | VINODCHANDRA DHIRAJLAL MEHTA | 3694812 | Buy |
7(2) | NIRUBEN VINODKUMAR MEHTA | 3694812 | Sell |
7(2) | NIRMALABEN A SHAH | 6575000 | Buy |
7(2) | MANUKANT CHANDULAL ZOTA | 6575000 | Sell |
7(2) | BHIKHALAL CHHOTALAL DOSHI | 1874901 | Buy |
7(2) | BHIKHALAL CHHOTALAL DOSHI | 2500208 | Buy |
7(2) | PRIYANKA VIREN ZOTA | 1137626 | Sell |
7(2) | DHARA KETAN ZOTA | 15032000 | Sell |
7(2) | KRINAL V ANKHAD | 6197375 | Buy |
7(2) | HIMNASHU MUKTILAL ZOTA | 6197375 | Sell |
7(2) | KINJAL NIKESH MEHTA | 6036350 | Buy |
7(2) | HIMNASHU MUKTILAL ZOTA | 6036350 | Sell |
7(2) | NIRUBEN VINODKUMAR MEHTA | 1143990 | Sell |
7(2) | RATILAL ZUMCHAND VORA | 1196840 | Sell |
7(2) | HIMANSHU MUKTILAL ZOTA HUF | 1649722 | Sell |
7(2) | VENIL SHRIKANTBHAI SIRIYA | 2401207 | Sell |
7(2) | RASILABEN MANUKANTBHAI ZOTA | 3648510 | Sell |
7(2) | ZOTA KETANKUMAR CHANDULAL (HUF) | 4734000 | Sell |
7(2) | INDUBEN MUKTILAL ZOTA | 2111890 | Sell |
Annual Reports of Zota Health Care LImited
Investor Complaints of Zota Health Care LImited
Date | Pending | Received | Disposed | Unresolved |
---|---|---|---|---|
31-Dec-2024 | 0 | 0 | 0 | 0 |
30-Sep-2024 | 0 | 0 | 0 | 0 |
30-Jun-2024 | 0 | 0 | 0 | 0 |
31-Mar-2024 | 0 | 0 | 0 | 0 |
31-Dec-2023 | 0 | 0 | 0 | 0 |
30-Sep-2023 | 0 | 0 | 0 | 0 |
30-Jun-2023 | 0 | 0 | 0 | 0 |
31-Mar-2023 | 0 | 0 | 0 | 0 |
31-Dec-2022 | 0 | 0 | 0 | 0 |
30-Sep-2022 | 0 | 0 | 0 | 0 |
30-Jun-2022 | 0 | 0 | 0 | 0 |
31-Mar-2022 | 0 | 0 | 0 | 0 |
31-Dec-2021 | 0 | 0 | 0 | 0 |
30-Sep-2021 | 0 | 0 | 0 | 0 |
30-Jun-2021 | 0 | 0 | 0 | 0 |
31-Mar-2021 | 0 | 0 | 0 | 0 |
31-Dec-2020 | 0 | 0 | 0 | 0 |
30-Sep-2020 | 0 | 0 | 0 | 0 |
30-Jun-2020 | 0 | 0 | 0 | 0 |
31-Mar-2020 | 0 | 0 | 0 | 0 |
31-Dec-2019 | 0 | 0 | 0 | 0 |
30-Sep-2019 | 0 | 0 | 0 | 0 |
30-Jun-2019 | 0 | 0 | 0 | 0 |
31-Mar-2019 | 0 | 0 | 0 | 0 |
31-Dec-2018 | 0 | 0 | 0 | 0 |
30-Sep-2018 | 0 | 0 | 0 | 0 |
30-Jun-2018 | 0 | 2 | 2 | 0 |
31-Mar-2018 | 0 | 0 | 0 | 0 |
31-Dec-2017 | 0 | 0 | 0 | 0 |
30-Sep-2017 | 1 | 0 | 1 | 0 |
30-Jun-2017 | 0 | 1 | 0 | 1 |
Event Calendar of Zota Health Care LImited
Purpose | Details |
---|---|
Results/Dividend | inter alia, to transact following business: 1) to consider and approved audited Financial Results for the year ended on March 31, 2017. 2) To recommend rate of final dividend. 3) To consider and transact any other business with the permission of the chair. |
Others | To consider and approved Director�s Report for the year ended on March 31, 2017.(2) To decide date, time and venue of 17th Annual General Meeting of the company.(3) To consider and decide book closure date and cut-off date for the payment of dividend and authorizing directors for opening dividend accounts.(4) To decide cut-off date and voting date for e-voting purpose and appointment of scrutinizer for conducting voting in Annual General Meeting.(5) To appoint M/s D S M & Co., Chartered Accountant, as a statutory auditor of the company.(6) To appoint M/s Pradeep K. Singhi & Associates, Chartered Accountant, as an internal auditor of the company.(7) To approve budget of corporate social responsibility activities of the company for the financial year 2017-18.(8) To transact any other business with the permission to the chair. |
Results | To consider and approve Unaudited Financial Results for the half year ended on September 30, 2017. |
Financial Results/Dividend/Other business matters | To consider and approve the audited financial results for the half year and year ended March 31, 2018, recommend rate of final dividend for the financial year 2017-18, if any, subject to approval of the members in ensuing Annual General Meeting of the Company and other business matters |
Other business matters | To consider and transact following business matters:1. To consider and approve Directorᅡメs Report for the year ended on March 31, 2018. 2. To decide date, time and venue of 18th Annual General Meeting of the company.3. To consider and decide book closure date for the payment of dividend and authorizing directors for opening dividend accounts.4. To decide cut-off date and voting date for e-voting purpose and appointment of scrutinizer for conducting voting in 18th Annual General Meeting.5. To approve budget of corporate social responsibility activities of the company for the financial year 2018-19.6. To transact any other business with the permission to the chair. |
Financial Results/Other business matters | To consider and approve the unaudited financial results for the period ended September 30, 2018 and other business matters |
Other business matters | 1. To approve migration of the Company from SME platform of National Stock Exchange (NSE EMERGE) to Main Board of NSE. 2. To appoint scrutinizer for conducting Postal Ballot Voting Process.3. To approve Postal Ballot Notice and Calendar of Events.4. To consider and transact any other business with the permission of the Chair. |
Financial Results/Dividend/Other business matters | 1. To consider and approve Audited Standalone and Consolidated Financial Results along with Audit Reports thereon for the half year and year ended on March 31, 2019;2.To recommend rate of final dividend, if any;3. To appoint Independent Directors; andother business matters |
Bonus/Other business matters | To consider bonus and other business matters |
Other business matters | The meeting of the Board of Directors of the Company is schedule to be held on Wednesday, August 21, 2019 at 11:00 A.M. at the registered office of the Company situated at Zota House, 2/896, Hira Modi Street, Sagrampura, Surat ᅡヨ 395002, Gujarat, inter alia, to transact following businesses:1. To consider and approve the Directorᅡメs Report for the year ended on March 31, 2019;2. To decide date, time and venue of 19th Annual General Meeting of the company;3. To consider and decide book closure dates for the purpose of payment of Dividend and 19th Annual General Meeting;4. To decide cut-off date for the purpose of e-voting and payment of Dividend;5. To decide voting dates for e-voting and to appoint Scrutinizer for conducting voting process in 19th Annual General Meeting;6. Re-appointments of the Whole-time Directors. |
Financial Results | To consider and approve the financial results for the period ended September 30, 2019 |
Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2019 and other business matters |
Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2020, dividend and other business matters |
Financial Results/Other business matters | 1. To consider and approve the Unaudited Standalone and Consolidated Financial Results along with Limited Review Reports thereon for the quarter ended June 30, 2020;2. To consider and approve the Director s Report for the year ended March 31, 2020;3. To approve the notice convening 20th Annual General Meeting of the company;4. To consider and decide book closure dates for Dividend payment and 20th Annual General Meeting;5. To decide cut-off date for the purpose of e-voting and payment of Dividend;6. To decide voting dates for e-voting and to appoint the Scrutinizer to scrutinize the remote e-voting process and the votes casted through e-voting system during the 20th Annual General Meeting of the Company. |
Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2020 and other business matters |
Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2020 and other business matters |
Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2021, dividend and other business matters |
Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2021 and other business matters |
Fund Raising/Other business matters | To consider Fund Raising and other business matters |
Other business matters | To consider other business matters |
Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2021 and other business matters |
Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2021 and other business matters |
Other business matters | Zota Health Care LImited has informed the Exchange about Board Meeting to be held on 02-Sep-2022 to consider Other business matters |
Other business matters | To consider other business matters |
Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2022 and other business matters |
Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2023, dividend and other business matters |
Fund Raising/Other business matters | To consider Fund Raising and other business matters |
Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2023 and other business matters |
Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2023 and other business matters |
Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2023 and other business matters |
Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2024, dividend and other business matters |
Fund Raising/Other business matters | To consider Fund Raising and other business matters |
Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2024 and other business matters |
Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2024 and other business matters |
Fund Raising/Other business matters | To consider Fund Raising and other business matters |
Share Transfers of Zota Health Care LImited
Voting Results of Zota Health Care LImited
Date of Mtg. | Mtg. Type | Resolution |
---|---|---|
28-SEP-2024 | AGM | TO RECEIVE, CONSIDER AND ADOPT THE AUDITED STANDALONE AND CONSOLIDATED FINANCIAL STATEMENTS OF THE COMPANY FOR THE FINANCIAL YEAR ENDED ON 31ST MARCH, 2024, TOGETHER WITH THE REPORTS OF THE BOARD OF DIRECTORS AND AUDITORS THEREON. |
28-SEP-2024 | AGM | TO APPROVE MATERIAL RELATED PARTY TRANSACTION |
28-SEP-2024 | AGM | TO RE-APPOINT MR. KAMLESH RAJANIKANT ZOTA (DIN: 00822705) AS A WHOLE- TIME DIRECTOR OF THE COMPANY |
28-SEP-2024 | AGM | TO RE-APPOINT MR. HIMANSHU MUKTILAL ZOTA (DIN: 01097722) AS A WHOLE-TIME DIRECTOR OF THE COMPANY |
28-SEP-2024 | AGM | TO RE-APPOINT MRS. JAYSHREEBEN NILESHKUMAR MEHTA (DIN: 08536399) AS A NON-EXECUTIVE INDEPENDENT DIRECTOR OF THE COMPANY |
28-SEP-2024 | AGM | TO RE-APPOINT MR. DHIREN PRAFULBHAI SHAH (DIN: 08536409) AS A NON-EXECUTIVE INDEPENDENT DIRECTOR OF THE COMPANY |
28-SEP-2024 | AGM | APPOINTMENT OF STATUTORY AUDITOR AND AUTHORISE DIRECTORS TO APPROVE THEIR REMUNERATION |
28-SEP-2024 | AGM | TO APPOINT A DIRECTOR IN PLACE OF MR. KETANKUMAR CHANDULAL ZOTA, DIRECTOR (HOLDING DIN: 00822594), WHO RETIRE BY ROTATION INnTERMS OF SECTION 152(6) OF THE COMPANIES ACT, 2013 AND BEING ELIGIBLE, SEEKS RE-APPOINTMENT |
28-SEP-2024 | AGM | DECLARATION OF FINAL DIVIDEND ON EQUITY SHARES @ 10% I.E. RE.1/- PER EQUITY SHARE FOR THE FINANCIAL YEAR 2023-24 |
27-AUG-2024 | Postal Ballot | TO RE-APPOINT MRS. BHUMI MAULIK DOSHI (DIN: 08456082) AS A NON- EXECUTIVE INDEPENDENT DIRECTOR |
27-AUG-2024 | Postal Ballot | TO RE-APPOINT MR. VITRAG SURESHKUMAR MODI (DIN: 08457204) AS A NON- EXECUTIVE INDEPENDENT DIRECTOR |
13-JUL-2024 | EGM | TO CONSIDER AND APPROVE INCREASE OF THE AUTHORIZED SHARE CAPITAL OF THE COMPANY BY AMENDING THE MEMORANDUM OF ASSOCIATION OF THE COMPANY |
13-JUL-2024 | EGM | ISSUANCE OF FULLY CONVERTIBLE WARRANTS ON A PREFERENTIAL BASIS TO PROMOTER GROUP AND NON - PROMOTER GROUP CATEGORY |
13-JUL-2024 | EGM | ISSUANCE OF EQUITY SHARES ON A PREFERENTIAL BASIS TO THE PROMOTER GROUP AND NON - PROMOTER GROUP CATEGORY |
27-JUN-2024 | Postal Ballot | REGULARISATION OF MR. VIREN MANUKANT ZOTA AS WHOLE- TIME DIRECTOR OF THE COMPANY |
27-JUN-2024 | Postal Ballot | TO APPROVE THE MATERIAL RELATED PARTY TRANSACTION |
27-JUN-2024 | Postal Ballot | TO INCREASE THE BORROWING LIMITS |
29-SEP-2023 | AGM | TO RECEIVE, CONSIDER AND ADOPT THE AUDITED STANDALONE AND CONSOLIDATED FINANCIAL STATEMENTS OF THE COMPANY FOR THE FINANCIAL YEAR ENDED ON MARCH 31, 2023, TOGETHER WITH THE REPORTS OF THE BOARD OF DIRECTORS AND AUDITORS THEREON. |
29-SEP-2023 | AGM | TO APPOINT A DIRECTOR IN PLACE OF MR. HIMANSHU MUKTILAL ZOTA, DIRECTOR (HOLDING DIN-01097722), WHO RETIRE BY ROTATION IN TERMS OF SECTION 152(6) OF THE COMPANIES ACT, 2013 AND BEING ELIGIBLE, SEEKS RE-APPOINTMENT. |
29-SEP-2023 | AGM | DECLARATION OF FINAL DIVIDEND ON EQUITY SHARES @10% I.E. RE. 1/- PER EQUITY SHARE FOR THE FINANCIAL YEAR 2022-23. |